Biobeat’s remote patient monitoring health-AI platform includes a wearable monitor which utilizes a photoplethysmography-based (PPG) sensor to continuously provide accurate patient readings of 13 health parameters, including cuffless blood pressure, pulse rate, respiratory rate, blood oxygen saturation, and more. Aggregated patient health data is viewed by medical staff via Biobeat’s secure cloud-based patient management platform, which utilizes a real-time early warning score system that incorporates advanced AI-based algorithms to provide alerts on patient health status and potential deterioration. Biobeat’s wearable devices are the first devices to be FDA-Cleared for cuffless non-invasive blood pressure monitoring and are also CE Mark certified.

CLEW offers real-time AI analytics platforms that enable healthcare providers to make informed clinical decisions by predicting life-threatening complications across diverse medical care settings. CLEW's goal is to provide advanced solutions to enhance outcomes and safety, optimize patient care, and effectively manage regulations and penalties, ultimately reducing cost of care. With its roots in the ICU, CLEW leverages its expertise in developing machine learning models to optimize clinical resources and assist providers in predicting patient deterioration across all care settings. By leveraging cutting-edge technology, CLEW is committed to driving healthcare innovation and delivering transformative results for patients and providers alike.

As the pioneer in remote patient management Commwell has taken its 35+ years of experience working with physicians and their patients remotely and developed a holistic constellation of products. Health eCare is the only remote patient management platform of its kind that enables complete customization and personalization in accordance with the needs of the customer. The platform records and manages essential patient conditions according to clinical protocols and integrates with the Commwell proprietary measuring solutions along with third party diagnostic devices. Physioglove is the only 12 lead ECG device for self-use by patients at home. Sentinel is a 2-channel wearable continuous 3-in-1 arrythmia monitor: Event, Telemetry and Holter.

DigiSense wearable technology device measures key parameters without touching the skin or body fluids, with a sensor attached externally to ALL types of mass-market diapers and on cloth diapers. It monitors and alerts for: Urine flow, Urine hue, Bowel movement, Flatulence, Bedsores, Falling, Ambient temperature, Respiratory rate, Sleeping quality and motion. No other product today can offer the capabilities and indicators to the elderly and baby's well-being and their care takers peace of mind. DigiSense invented the world’s first unified technology and platform with high reliability and low production cost along with strong IP rights that will enable to monitor vital information, in real time, by multiple users in home environment, hospitals and nursing homes.

Kemtai is a computer vision exercise platform for physiotherapy, MSK and fitness. It runs on any device with a camera (mobile phones, computers, tablets) it provides patients with real-time feedback and guidance and provides therapists (or the health services providers) with the data of the patient's performance in order to further personalize their home exercise protocols.

Medcase connects healthcare businesses with expert clinicians worldwide for innovative AI and telehealth solutions. They offer services including clinician recruitment, project delivery, patient visits, EHR integration, and more. Medcase's marketplace of clinicians provides scalable access to high-quality and compliant services in 20+ countries, 24+ specialties, and 31 languages. They simplify access to healthcare infrastructure and personnel through their cloud-based platform and Health Cloud, with a saas + consumption based model for clinic as a service. Medcase is compliant with HIPAA and the Sunshine Act for client confidence and integrity.

TechnoPulm is shifting the Pulmonary Functional test paradigm. By using the Technopulm STS handheld device, Pulmonary Functional Tests can be performed in the community and avoid the need of sending patients to the hospital to By have respiratory disease diagnostics. Technopulm completed the product development with a successful a clinical trial on 161 subjects at Kaplan Hospital, holding granted patents in the US and Europe, completed the quality assurance system that complies with the ISO 13845 standard, and finalized the submission files to the FDA/CE. These days TechnoPulm is conducting a clinical pilot jointly with two leading HMOs in Israel to diagnose lung diseases from the community and is working to create collaborations in the United States and Europe.